Mitochondria HSP90: the target to inactivate in cancer therapy?

被引：3
|
作者：
Didelot, Celine [1 ]
Garrido, Carmen [1 ]
机构：
[1] INSERM, Fac Med, UMR 866, F-21049 Dijon, France
来源：
M S-MEDECINE SCIENCES | 2008年 / 24卷 / 04期
关键词：
D O I：
10.1051/medsci/2008244363
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：363 / 364
页数：2
相关论文
共 50 条
  • [1] Hsp90: A novel target for cancer therapy
    Solit, David B.
    Rosen, Neal
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (11) : 1205 - 1214
  • [2] Hsp90: an emerging target for breast cancer therapy
    Beliakoff, J
    Whitesell, L
    ANTI-CANCER DRUGS, 2004, 15 (07) : 651 - 662
  • [3] Extracellular HSP90: An Emerging Target for Cancer Therapy
    Sidera, Katerina
    Patsavoudi, Evangelia
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2009, 4 (01) : 51 - 58
  • [4] The Hsp90 chaperone complex - A potential target for cancer therapy?
    Darimont, BD
    WORLD JOURNAL OF GASTROENTEROLOGY, 1999, 5 (03) : 195 - 198
  • [5] The Hsp90 chaperone complex as a novel target for cancer therapy
    Goetz, MP
    Toft, DO
    Ames, MM
    Erlichman, C
    ANNALS OF ONCOLOGY, 2003, 14 (08) : 1169 - 1176
  • [6] Targeting HSP90 for cancer therapy
    Mahalingam, D.
    Swords, R.
    Carew, J. S.
    Nawrocki, S. T.
    Bhalla, K.
    Giles, F. J.
    BRITISH JOURNAL OF CANCER, 2009, 100 (10) : 1523 - 1529
  • [7] The Hsp90 chaperone complex-A potential target for cancer therapy?
    Beatrice D. Darimont
    World Journal of Gastroenterology, 1999, (03) : 195 - 198
  • [8] HSP90 as a new therapeutic target for cancer therapy: the story unfolds
    Maloney, A
    Workman, P
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (01) : 3 - 24
  • [9] Targeting HSP90 for cancer therapy
    D Mahalingam
    R Swords
    J S Carew
    S T Nawrocki
    K Bhalla
    F J Giles
    British Journal of Cancer, 2009, 100 : 1523 - 1529
  • [10] The Therapeutic Target Hsp90 and Cancer Hallmarks
    Miyata, Yoshihiko
    Nakamoto, Hitoshi
    Neckers, Len
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (03) : 347 - 365
12345